Why Is End-of-Life Spending So High? Evidence from Cancer Patients | Citedby Results | The Review of Economics and Statistics | MIT Press

Skip to Main Content

Skip Nav Destination

Why Is End-of-Life Spending So High? Evidence from Cancer Patients

The Review of Economics and Statistics (2023) 105 (3): 511–527.

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

The Economic Burden of Burnout

Arash Nekoei
Jósef Sigurdsson
Dominik Wehr

SSRN Electronic Journal (2024)

Risk adjustment for regional healthcare funding allocations with ensemble methods: an empirical study and interpretation

Tuukka Holster
Shaoxiong Ji
Pekka Marttinen

The European Journal of Health Economics (2024) 25 (7): 1117.

Aging populations and expenditures on health

Malene Kallestrup-Lamb
Alexander O.K. Marin
Seetha Menon
Jes Søgaard

The Journal of the Economics of Ageing (2024) 29: 100518.

Organizing the Good Death: Ethics and Values-Work in the Sower Hospice

M. Dolores del Rio
Roy Suddaby

Journal of Business Ethics (2024)

Why is end‐of‐life inpatient cost high among cancer patients? A prospective cohort study

Ishwarya Balasubramanian
Chetna Malhotra

Cancer Medicine (2024) 13 (4)

The Economic Burden of Burnout

Arash Nekoei
Jósef Sigurdsson
Dominik Wehr

SSRN Electronic Journal (2024)

Elevated end‐of‐life spending: A new measure of potentially wasteful health care spending at the end of life

Yongkang Zhang
Atul Gupta
Sean Nicholson
Jing Li

Health Services Research (2023) 58 (1): 186.